A Professional Development Programme (ProDeveloP) for Newly Graduated Nurses
Launched by MÄLARDALEN UNIVERSITY · Dec 18, 2024
Trial Information
Current as of July 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The primary outcomes will be role clarity, task mastery, social acceptance, recovery and stress. The researchers will compare the results of the primary outcomes with those of a control group measure. Secondary outcomes will be experience of the intervention, transition support, job satisfaction and intention to leave.
Informed consent was signed prior to participation in the study. The ethical application has been approved by the Ethics Authority IS, diary number 2022-05682-0.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Registered nurses in Sweden employed as Newly Graduated Nurses (NGNs) in a county in central Sweden participating in the ProDeveloP, the intervention group.
- • Registered nurses in Sweden employed as Newly Graduated Nurses (NGNs) in a county in central Sweden, NGNs participating in the introduction programme prior to the study, not participating in the ProDeveloP, the control group.
- • Experienced registered nurses as facilitators for the dialogue groups for the NGNs in the intervention.
- • Managers at the county hospital for the NGNs participating in the intervention.
- Exclusion criteria:
- • • Managers without NGNs participated in the intervention.
About Mälardalen University
Mälardalen University is a leading academic institution in Sweden, renowned for its commitment to innovative research and development across various fields, including health sciences. As a clinical trial sponsor, the university leverages its multidisciplinary expertise to advance evidence-based practices and contribute to the understanding of complex health issues. Through collaboration with healthcare professionals and industry partners, Mälardalen University aims to enhance patient care and promote public health by facilitating high-quality clinical research that adheres to rigorous ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Västerås, , Sweden
Patients applied
Trial Officials
Margareta Asp, Professor
Principal Investigator
Mälardalens University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported